Fatigue News and Research

RSS

Cessation fatigue predicts relapse rate after attempts to quit smoking

Although there is good news about smoking -- only 14 percent of Americans smoke, the lowest number ever, according to a 2017 National Health Interview Survey -- challenges remain. In a given year, more than 40 percent of smokers make no attempt to quit.

20 Nov 2018

Noise pollution in hospital impact quality and safety of healthcare

In an editorial published today in the BMJ, researchers from King's College London and the University of the Arts London argue that it is a worsening problem, with levels regularly exceeding international recommendations.

19 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

New pharmacological agent shows promise for prevention of heart rhythm disorders

A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias.

15 Nov 2018

Surgical menopause leads to more disrupted sleep than natural menopause

With insomnia being a common symptom of menopause, research has shown that women who undergo surgical menopause are at an increased risk of insomnia compared with women who go through it naturally.

14 Nov 2018

Sleep quality found to be worse for women who undergo surgical menopause

Insomnia is one of the most common symptoms of menopause, with nearly 20% of postmenopausal women reporting sleep disturbances.

14 Nov 2018

Survey: Complementary and alternative medicine is widely used by general population in England

Use of practitioner-led complementary and alternative medicine (CAM), such as acupuncture, massage, osteopathy and chiropractic treatment, rose from 12 per cent of the population in 2005 to 16 per cent of the population in 2015, according to a survey led by researchers at the University of Bristol's Centre for Academic Primary Care.

14 Nov 2018

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Targeted tumor radiation provides a feasible treatment option for children with difficult-to-treat liver cancer, according to a new study published today in the journal Pediatric Blood and Cancer.

8 Nov 2018

TBIMSC completes 30 years of collaborative research to improve TBI outcomes

Over the past three decades, the Traumatic Brain Injury Model Systems Center program has served as a critical source of research to improve care and outcomes for patients and families affected by traumatic brain injury.

8 Nov 2018

MedicalTek develops world's first endoscope visualization system with adjustable 3D effects

There is a common belief that 3D visualization provides a better image to minimally invasive surgery with depth perception.

7 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Researchers develop new device that improves balance in veterans with Gulf War illness

Gulf War veterans with unexplained illnesses that cause fatigue, headaches, respiratory disorders and memory problems can improve their balance with a device developed by Rutgers University researchers.

5 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Researchers discover biomarker for most common type of heart failure

A team led by a Cedars-Sinai physician-scientist has discovered a biomarker--a protein found in the blood--for the most common type of heart failure, a new study published today in JAMA Cardiology shows.

1 Nov 2018

New eye-tracking glasses create more realistic experience for augmented reality enthusiasts

Battery-free eye-tracking glasses developed at Dartmouth College could create an even more realistic experience for augmented reality enthusiasts. The new technology improves player controls for gaming and allows for more accurate image displays.

30 Oct 2018

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.

29 Oct 2018

MIT researchers devise way to help blood cells regenerate after radiation therapy

Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.

24 Oct 2018

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.

23 Oct 2018

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

EUSA Pharma welcomes the news that FOTIVDA (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology clinical practice guidelines for advanced renal cell carcinoma, anticipated to be published at the end of this year.

22 Oct 2018

Fatigue News and Research

Cessation fatigue predicts relapse rate after attempts to quit smoking

Noise pollution in hospital impact quality and safety of healthcare

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Nexus announces availability of Arsenic Trioxide Injection in the US

New pharmacological agent shows promise for prevention of heart rhythm disorders

Surgical menopause leads to more disrupted sleep than natural menopause

Sleep quality found to be worse for women who undergo surgical menopause

Survey: Complementary and alternative medicine is widely used by general population in England

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

TBIMSC completes 30 years of collaborative research to improve TBI outcomes

MedicalTek develops world's first endoscope visualization system with adjustable 3D effects

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Researchers develop new device that improves balance in veterans with Gulf War illness

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Researchers discover biomarker for most common type of heart failure

New eye-tracking glasses create more realistic experience for augmented reality enthusiasts

Investigational drug targeting the opioid system may help reduce symptoms of major depression

MIT researchers devise way to help blood cells regenerate after radiation therapy

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News